CLINICAL_TRIALS
trial_result
· 2021-03-02
Clinical Trial Update: Efficacy and Safety of TMBCZG in Mild to Moderate Vascular Dementia [Phase 2]
Summary
Phase 2 trial update on TMBCZG showing efficacy and safety data in mild to moderate vascular dementia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dongzhimen Hospital, Beijing | Conditions: Vascular Dementia | Phase 2 | Status: COMPLETED